Dr. Chau Dang, MD – New York, NY

Overview of Dr. Dang

Dr. Chau Dang is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center, NYC Health + Hospitals / Bellevue, Phelps Memorial Hospital Center, and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Medical University of South Carolina College of Medicine and has been in practice 25 years. Dr. Dang accepts several types of health insurance, listed below. She is one of 468 doctors at Memorial Sloan-Kettering Cancer Center and one of 61 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

• New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1996 - 1999

• Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1993 - 1996

• Eastern Virginia Medical SchoolInternship, Transitional Year, 1992 - 1993

• Medical University of South CarolinaClass of 1992

Certifications & Licensure

• FL State Medical License 2021 - Present

• NJ State Medical License 2019 - 2025

• NY State Medical License 1996 - 2025

• PA State Medical License 1994 - 1996

Clinical Trials

Publications & Presentations

PubMed

• Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).

  Geyer, C., Blum, J., Yothers, G., Asmar, L., Flynn, P., Robert, N., Hopkins, J., O'Shaughnessy, J., Rastogi, P., Puhalla, S., Hilton, C., Dang, C., Gómez, H., Vukelja,...> ;Journal of Clinical Oncology. 2024 Feb 9

• Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.

  Stephanie Gu, Stephen Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael Marchetti, Andrea P Moy, Chau Dang, Shanu Modi, Diana Lake, Sarah Noor, Mario E ...> ;Breast Cancer Research and Treatment. 2024 Jan 1

• Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

  Anthony F Yu, I-Hsin Lin, Justine Jorgensen, Robert Copeland-Halperin, Stephanie Feldman, Amare Assefa, Michelle N Johnson, Chau T Dang, Jennifer E Liu, Richard M Stei...> ;Journal of the American Heart Association. 2023 Oct 3
• Join now to see all

Journal Articles

• Left Ventricular Ejection Fraction Monitoring Adherence Rates  

  Chau T Dang, Sandra M Swain, Anne Blaes, ScienceDirect

Press Mentions

• Impressive Disease Control in Metastatic Triple-Negative Breast CancerMay 14th, 2021

• Emerging Cardio-Oncology Field Fights Heart Disease in Breast Cancer PatientsOctober 30th, 2019

• PCI in Cancer; Beta-Blocker Prophylaxis; Stress Echo Predicts Cancer DeathsDecember 10th, 2018

• Join now to see all

Professional Memberships

Hospital Affiliations

Insurance Accepted

• Aetna Choice POS II
  Aetna HMO
  BCBS Blue Card PPO
  CIGNA HMO
  CIGNA Open Access
  CIGNA PPO
  Empire BCBS HMO
  Empire BCBS PPO
  First Health PPO
  GHI PPO
  Great West PPO
  

  Humana ChoiceCare Network PPO
  Multiplan PHCS PPO
  Multiplan PPO
  MVP Healthcare PPO
  Oxford Health Freedom
  Oxford Health Liberty
  QualCare HMO
  QualCare PPO
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment